These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36411134)

  • 1. Evaluation of three hemagglutinin-based vaccines for the experimental control of a panzootic clade 2.3.4.4b A(H5N8) high pathogenicity avian influenza virus in mule ducks.
    Niqueux É; Flodrops M; Allée C; Lebras MO; Pierre I; Louboutin K; Guillemoto C; Le Prioux A; Le Bouquin-Leneveu S; Keïta A; Amelot M; Martenot C; Massin P; Cherbonnel-Pansart M; Briand FX; Schmitz A; Cazaban C; Dauphin G; Delquigny T; Lemière S; Watier JM; Mogler M; Tarpey I; Grasland B; Eterradossi N
    Vaccine; 2023 Jan; 41(1):145-158. PubMed ID: 36411134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Clade 2.3.2 H5-Recombinant Baculovirus Vaccine in Protecting Muscovy and Pekin Ducks from Clade 2.3.4.4 H5N8 Highly Pathogenic Avian Influenza Infection.
    Sultan HA; Arafa AE; Talaat S; Gaballa AA; Kilany WH; Elfeil WK; Shehata AA; Amarin N
    Avian Dis; 2019 Mar; 63(sp1):219-229. PubMed ID: 31713400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Determinants for Virulence and Transmission of the Panzootic Avian Influenza Virus H5N8 Clade 2.3.4.4 in Pekin Ducks.
    Scheibner D; Breithaupt A; Luttermann C; Blaurock C; Mettenleiter TC; Abdelwhab EM
    J Virol; 2022 Jul; 96(13):e0014922. PubMed ID: 35670594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of inactivated avian influenza virus and Newcastle disease virus bivalent vaccination program against newly circulated H5N8 and NDV strains.
    Azab AA; Yehia N; Makhareta M; Samir M; Shoukry A; Elhalem Mohamed AA; Alhag SK; Alwabli AS; El-Saadony MT; El-Tarabily KA; Soliman MA
    Poult Sci; 2023 Oct; 102(10):102952. PubMed ID: 37634266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of the protective efficacy of two avian influenza H5 vaccines against clade 2.3.4.4b H5N8 highly pathogenic avian influenza virus in commercial broilers.
    El-Shall NA; Awad AM; Sedeik ME
    Res Vet Sci; 2021 Nov; 140():125-133. PubMed ID: 34425414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-Like Particle Based Vaccine Provides High Level of Protection Against Homologous H5N8 HPAIV Challenge in Mule and Pekin Duck, Including Prevention of Transmission.
    Tatár-Kis T; Dán Á; Felföldi B; Bálint Á; Rónai Z; Dauphin G; Pénzes Z; El-Attrache J; Gardin Y; Palya V
    Avian Dis; 2019 Mar; 63(sp1):193-202. PubMed ID: 31131577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus.
    Niqueux E; Guionie O; Amelot M; Jestin V
    Vaccine; 2013 Aug; 31(38):4121-8. PubMed ID: 23845804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
    Kilany WH; Safwat M; Mohammed SM; Salim A; Fasina FO; Fasanmi OG; Shalaby AG; Dauphin G; Hassan MK; Lubroth J; Jobre YM
    PLoS One; 2016; 11(6):e0156747. PubMed ID: 27304069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).
    Pantin-Jackwood MJ; Kapczynski DR; DeJesus E; Costa-Hurtado M; Dauphin G; Tripodi A; Dunn JR; Swayne DE
    Avian Dis; 2016 Mar; 60(1):22-32. PubMed ID: 26953940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a Recombinant Turkey Herpesvirus AI (H5) Vaccine in Preventing Transmission of Heterologous Highly Pathogenic H5N8 Clade 2.3.4.4b Challenge Virus in Commercial Broilers and Layer Pullets.
    Palya V; Tatár-Kis T; Walkóné Kovács E; Kiss I; Homonnay Z; Gardin Y; Kertész K; Dán Á
    J Immunol Res; 2018; 2018():3143189. PubMed ID: 30584541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral tropism and detection of clade 2.3.4.4b H5N8 highly pathogenic avian influenza viruses in feathers of ducks and geese.
    Gaide N; Foret-Lucas C; Figueroa T; Vergne T; Lucas MN; Robertet L; Souvestre M; Croville G; Le Loc'h G; Delverdier M; Guérin JL
    Sci Rep; 2021 Mar; 11(1):5928. PubMed ID: 33723295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Two Licensed Avian Influenza H5 Vaccines Against Challenge with a 2015 U.S. H5N2 clade 2.3.4.4 Highly Pathogenic Avian Influenza Virus in Domestic Ducks.
    Pantin-Jackwood MJ; DeJesus E; Costa-Hurtado M; Smith D; Chrzastek K; Kapczynski DR; Suarez DL
    Avian Dis; 2019 Mar; 63(1):90-96. PubMed ID: 31251524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Introductions of Reassorted Highly Pathogenic Avian Influenza H5Nx Viruses Clade 2.3.4.4b Causing Outbreaks in Wild Birds and Poultry in The Netherlands, 2020-2021.
    Engelsma M; Heutink R; Harders F; Germeraad EA; Beerens N
    Microbiol Spectr; 2022 Apr; 10(2):e0249921. PubMed ID: 35286149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection Afforded by a Recombinant Turkey Herpesvirus-H5 Vaccine Against the 2014 European Highly Pathogenic H5N8 Avian Influenza Strain.
    Steensels M; Rauw F; van den Berg T; Marché S; Gardin Y; Palya V; Lambrecht B
    Avian Dis; 2016 May; 60(1 Suppl):202-9. PubMed ID: 27309056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural and Experimental Persistence of Highly Pathogenic H5 Influenza Viruses in Slurry of Domestic Ducks, with or without Lime Treatment.
    Schmitz A; Pertusa M; Le Bouquin S; Rousset N; Ogor K; LeBras MO; Martenot C; Daniel P; Belen Cepeda Hontecillas A; Scoizec A; Morin H; Massin P; Grasland B; Niqueux E; Eterradossi N
    Appl Environ Microbiol; 2020 Nov; 86(24):. PubMed ID: 33008818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral shedding and environmental dispersion of two clade 2.3.4.4b H5 high pathogenicity avian influenza viruses in experimentally infected mule ducks: implications for environmental sampling.
    Filaire F; Bertran K; Gaide N; Valle R; Secula A; Perlas A; Foret-Lucas C; Nofrarías M; Cantero G; Croville G; Majó N; Guerin JL
    Vet Res; 2024 Aug; 55(1):100. PubMed ID: 39135123
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Foret-Lucas C; Figueroa T; Coggon A; Houffschmitt A; Dupré G; Fusade-Boyer M; Guérin JL; Delverdier M; Bessière P; Volmer R
    Microbiol Spectr; 2023 Feb; 11(1):e0422922. PubMed ID: 36625654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H5-based DNA constructs derived from selected highly pathogenic H5N1 avian influenza virus induce high levels of humoral antibodies in Muscovy ducks against low pathogenic viruses.
    Guionie O; Niqueux E; Amelot M; Bougeard S; Jestin V
    Virol J; 2014 Apr; 11():74. PubMed ID: 24762011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity of H5N8 avian influenza virus in chickens and in duck breeds and the role of MX1 and IFN-α in infection outcome and transmission to contact birds.
    El-Shall NA; Abd El Naby WSH; Hussein EGS; Yonis AE; Sedeik ME
    Comp Immunol Microbiol Infect Dis; 2023 Sep; 100():102039. PubMed ID: 37591150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory disease due to mixed viral infections in poultry flocks in Egypt between 2017 and 2018: Upsurge of highly pathogenic avian influenza virus subtype H5N8 since 2018.
    Hassan KE; El-Kady MF; El-Sawah AAA; Luttermann C; Parvin R; Shany S; Beer M; Harder T
    Transbound Emerg Dis; 2021 Jan; 68(1):21-36. PubMed ID: 31297991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.